LIFECELL/MEDTRONIC PORCINE HEART VALVE PACT VALUED AT $26.5 MIL.
This article was originally published in The Gray Sheet
Executive Summary
LIFECELL/MEDTRONIC PORCINE HEART VALVE PACT VALUED AT $26.5 MIL. to LifeCell over the life of the deal, excluding development fees, LifeCell estimates. The definitive agreement, signed March 3, calls for Medtronic to fund development of "universal tissue heart valves engineered with LifeCell's proprietary technology." The aim is to create porcine heart valves with extended durability by countering calcification.